These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Varicella zoster virus reactivation in hemodialysis patients: manifestations, treatment, complications and outcome. Mesar I; Basić-Jukić N; Hudolin T; Katalinić L; Kes P Acta Clin Croat; 2011 Dec; 50(4):549-52. PubMed ID: 22649885 [TBL] [Abstract][Full Text] [Related]
10. Clinical features and risk factors for developing varicella zoster virus dissemination following hematopoietic stem cell transplantation. Umezawa Y; Kakihana K; Oshikawa G; Kobayashi T; Doki N; Sakamaki H; Ohashi K Transpl Infect Dis; 2014 Apr; 16(2):195-202. PubMed ID: 24438510 [TBL] [Abstract][Full Text] [Related]
11. Prevention of VZV infection in immunosuppressed patients using antiviral agents. Boeckh M Herpes; 2006 Nov; 13(3):60-5. PubMed ID: 17147908 [TBL] [Abstract][Full Text] [Related]
12. One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. Erard V; Guthrie KA; Varley C; Heugel J; Wald A; Flowers ME; Corey L; Boeckh M Blood; 2007 Oct; 110(8):3071-7. PubMed ID: 17515400 [TBL] [Abstract][Full Text] [Related]
13. Impact of the duration of antiviral prophylaxis on rates of varicella-zoster virus reactivation disease in autologous hematopoietic cell transplantation recipients. Truong Q; Veltri L; Kanate AS; Hu Y; Craig M; Hamadani M; Cumpston A Ann Hematol; 2014 Apr; 93(4):677-82. PubMed ID: 24097085 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe? Dasanu CA; Alexandrescu DT J Oncol Pharm Pract; 2010 Dec; 16(4):266-8. PubMed ID: 19965947 [TBL] [Abstract][Full Text] [Related]